{"doc_id": "mu_no11_sep21_pr.pdf", "chunk_id": "mu_no11_sep21_pr.pdf::0000", "char_start": 0, "char_end": 2000, "pages": [1], "text": "September 2021\nVolume 37 | Number 11\nMedicaid Hospital Inpatient Billing Discharge Status Codes\nHospitals must correctly identify and properly code whether patients are transferred or discharged, since\nthis will affect Medicaid hospital inpatient billing and payments. For additional information, providers can refer\nto the May 2013 issue of the Medicaid Update article titled Medicaid Billing –Patient Status Codes, found at:\nhttps://www.health.ny.gov/health_care/medicaid/program/update/2013/may13_mu.pdf.\nEffective August 21, 2021, according to the New York Codes, Rules and Regulations (NYCRR), Title 10,\n§86-1.15, discharges (in a general hospital acute care setting) shall mean those inpatients whose admission\nto the facility occurred on or after December 1, 2009, and:\n• the patient is released from the facility to a non-acute care setting; or\n• the patient dies in the facility; or\n• the patient is transferred to a facility or unit that is exempt from the case-based payment system,\nexcept when the patient is a newborn transferred to an exempt hospital for neonatal services; or\n• the patient is a neonate being released from a hospital (providing neonatal specialty services) back to\nthe community hospital of birth for weight gain.\nA transfer patient is defined as a patient who:\n• is not discharged, as stated above,\n• is not transferred among two or more divisions of merged or consolidated facilities\n• is not assigned to a Diagnosis Related Group (DRG) specifically identified as a DRG for transferred\npatients only, and\n• meets one of the following conditions:\nis transferred from an acute care facility reimbursed under the DRG case-based payment\nsystem to another acute care facility reimbursed under the same system; or is transferred to\nan out-of-state acute care facility; or\nis a neonate who is being transferred to an exempt hospital for neonatal services.\nHospitals must ensure the accuracy of the patient discharge status coding on correct Medicaid claims.\nAdditional Info", "chunk_type": "text"}
{"doc_id": "mu_no11_sep21_pr.pdf", "chunk_id": "mu_no11_sep21_pr.pdf::0001", "char_start": 1750, "char_end": 3750, "pages": [1, 2], "text": "ferred to\nan out-of-state acute care facility; or\nis a neonate who is being transferred to an exempt hospital for neonatal services.\nHospitals must ensure the accuracy of the patient discharge status coding on correct Medicaid claims.\nAdditional Information:\n• For additional information regarding NYCRR, Title 10, §86-1.15, and transfer payments (NYCRR, Title\n10, Part 86-1.21), providers should refer to the NYS Department of Health (DOH) “New York Codes,\nRules and Regulations” web site at: https://www.health.ny.gov/regulations/nycrr/title_10/.\n• For inpatient billing guidelines, providers should refer to the eMedNY NYS UB-04 Billing Guidelines\nat: https://www.emedny.org/ProviderManuals/Inpatient/PDFS/Inpatient_Billing_Guidelines.pdf.\n***************************************************************************************************************\n\nKathy Hochul\nGovernor\nState of New York\nHoward A. Zucker, M.D., J.D.\nCommissioner\nNew York State\nDepartment of Health\nBrett R. Friedman\nActing Medicaid Director\nOffice of Health Insurance Programs\nThe Medicaid Update is a monthly publication of the New York State Department of Health.\nIn This Issue…\nMedicaid Hospital Inpatient Billing Discharge Status Codes .......................................................................... Cover\nPolicy and Billing\nAttention: Applied Behavior Analysis Providers ..................................................................................................3\nReminder: Existing New York State Medicaid Policy\nfor Drugs, Supplies, and Procedures Used for Sexual or Erectile Dysfunction.........................................................3\nAll Providers\nMedicaid Consumer Fact Sheets Now Available ................................................................................................7\nNY State of Health: Higher Income New Yorkers May Now Qualify\nfor Financial Assistance to Lower the Cost of Health Coverage .........................................................................", "chunk_type": "text"}
{"doc_id": "mu_no11_sep21_pr.pdf", "chunk_id": "mu_no11_sep21_pr.pdf::0002", "char_start": 3500, "char_end": 5500, "pages": [2, 3], "text": "...................................................7\nNY State of Health: Higher Income New Yorkers May Now Qualify\nfor Financial Assistance to Lower the Cost of Health Coverage ............................................................................7\nClozapine Risk Evaluation and Mitigation Strategy Deadline ................................................................................8\nProvider Directory .................................................................................................................................9\nSeptember 2021 New York State Medicaid Update pg. 2\n\nPolicy and Billing\nAttention: Applied Behavior Analysis Providers\nApplied Behavior Analysis (ABA) services provided by New York State (NYS) Medicaid enrolled Licensed\nBehavior Analysts (LBAs), Certified Behavior Analyst Assistants (CBAAs), or other individuals specified under\nArticle 167 of NYS Education Law working under the supervision of LBAs will be carved out of the Medicaid\nManaged Care (MMC) benefit package. Effective October 1, 2021, NYS Medicaid enrolled LBAs can bill\nMedicaid fee-for-service (FFS) for ABA services provided to MMC members until further notice. The ABA\nProvider Manual and Fee Schedule, published by the NYS Department of Health (DOH) via eMedNY “Applied\nBehavior Analysts (ABA)” web page located at: https://www.emedny.org/ProviderManuals/ABA/index.aspx,\nprovides coverage policy, billing guidance and fee schedules for ABA services.\nAdditional Information:\n• Additional information regarding ABA services can be found in the article titled Coverage of Applied\nBehavior Analysis in the July 2021 issue of the Medicaid Update, located at:\nhttps://www.health.ny.gov/health_care/medicaid/program/update/2021/docs/mu_no09_jul21_pr.pdf.\n• Please note: Current Procedural Terminology (CPT) code “97156” [Family adaptive behavior\ntreatment guidance, administered by physician or other qualified health care professional, with or\nwithout the patient present, face-to-face with ", "chunk_type": "text"}
{"doc_id": "mu_no11_sep21_pr.pdf", "chunk_id": "mu_no11_sep21_pr.pdf::0003", "char_start": 5250, "char_end": 7250, "pages": [3], "text": "ul21_pr.pdf.\n• Please note: Current Procedural Terminology (CPT) code “97156” [Family adaptive behavior\ntreatment guidance, administered by physician or other qualified health care professional, with or\nwithout the patient present, face-to-face with guardian(s)/caregiver(s), for 15 minutes each] has been\nadded to the published ABA Provider Manual and Fee Schedule.\n• CPT code “97156” can only be billed when the service is delivered in concert with care of the patient\nas part of the patient treatment plan.\n***************************************************************************************************************\nReminder: Existing New York State Medicaid Policy for Drugs,\nSupplies, and Procedures Used for Sexual or Erectile Dysfunction\nIn accordance with Chapter 645 of the Laws of 2005, the New York State (NYS) Medicaid program does\nnot cover prescription or physician administered drugs used for the treatment of sexual dysfunction (SD) or\nerectile dysfunction (ED). Additionally, Medicaid does not reimburse any supplies or procedures used to\ntreat SD/ED for persons required to register as sex offenders. Providers must verify that Medicaid members\nreceiving any procedures or supplies which may be used for these indications are not listed as registered sex\noffenders. There may be limited exceptions where some of these services are covered for members on the\nsex offender list, if their conditions are not related to SD/ED. These situations will require medical review by\nNYS Department of Health (DOH) for Medicaid fee-for-service (FFS) and by each impacted Medicaid\nManaged Care (MMC) Plan.\nMedicaid Fee-For-Service\nFor SD/ED procedures, physician administered drugs or supplies that require Prior Approval (PA), the NYS\nDepartment of Health (DOH) will verify if members are registered as sex offenders during the PA process.\nPrior to performing inpatient procedures related to SD/ED treatment, providers must contact the Bureau of\nMedical Review at (800) 342-3005. Outpatient p", "chunk_type": "text"}
{"doc_id": "mu_no11_sep21_pr.pdf", "chunk_id": "mu_no11_sep21_pr.pdf::0004", "char_start": 7000, "char_end": 9000, "pages": [3, 4], "text": "ent of Health (DOH) will verify if members are registered as sex offenders during the PA process.\nPrior to performing inpatient procedures related to SD/ED treatment, providers must contact the Bureau of\nMedical Review at (800) 342-3005. Outpatient pharmacy services that provide phosphodiesterase type-5\n(PDE-5) inhibitors require PA to ensure clinical criteria are met. Specific clinical criteria can be found on the\nNYS Medicaid Fee-For-Service (FFS) Preferred Drug List at:\nhttps://newyork.fhsc.com/downloads/providers/NYRx_PDP_PDL.pdf. Providers seeking PA can contact the\nMagellan Clinical Call Center at (800) 343-9000.\nSeptember 2021 New York State Medicaid Update pg. 3\n\nMedicaid Managed Care Plans\nPrior to approving requests for any SD/ED related drugs, supplies, or procedures, MMC Plans [including\nmainstream MMC Plans, HIV (Human Immunodeficiency Virus) Special Needs Plans (SNPs), as well as\nHealth and Recovery Plans (HARPs)] are required to submit requests for information regarding enrollee status\non the sex offender registry to the NYS DOH through the Health Commerce System (HCS) Erectile\nDysfunction Verification System (EDVS), each time there are requests for these services.\nNYS Medicaid FFS has compiled the following list of services used for the treatment of SD/ED:\nCurrent Procedural\nTerminology (CPT) Codes Descriptions\nand Physician administered\n(J-Code Drugs)\n“37788” Penile revascularization, artery, with or without vein graft\n“37790” Penile venous occlusive procedure\n“54400” Insertion of penile prosthesis; non-inflatable (semi-rigid)\n“54401” Insertion of penile prosthesis; inflatable (self-contained)\n“54405” Insertion of multi-component, inflatable penile prosthesis, including\nplacement of pump, cylinders, and reservoir\n“54408” Repair of component(s) of a multi-component, inflatable penile prosthesis\n“54410” Removal and replacement of all component(s) of a multi-component,\ninflatable penile prosthesis at the same operative session\n“54411” Removal and repla", "chunk_type": "text"}
{"doc_id": "mu_no11_sep21_pr.pdf", "chunk_id": "mu_no11_sep21_pr.pdf::0005", "char_start": 8750, "char_end": 10750, "pages": [4], "text": "reservoir\n“54408” Repair of component(s) of a multi-component, inflatable penile prosthesis\n“54410” Removal and replacement of all component(s) of a multi-component,\ninflatable penile prosthesis at the same operative session\n“54411” Removal and replacement of all components of a multi-component\ninflatable penile prosthesis through an infected field at the same operative\nsession, including irrigation and debridement of infected tissue\n“54416” Removal and replacement of non-inflatable (semi-rigid) or inflatable (self-\ncontained) penile prosthesis at the same operative session\n“54417” Removal and replacement of non-inflatable (semi-rigid) or inflatable (self-\ncontained) penile prosthesis through an infected field at the same\noperative session, including irrigation and debridement of infected tissue\n“55870” Electroejaculation\n“J0270” Injection, alprostadil, 1.25 mcg (code may be used for Medicare when\ndrug administered under the direct supervision of a physician, not for use\nwhen drug is self-administered) *\n“J0275” Alprostadil urethral suppository (code may be used for Medicare when\ndrug administered under the direct supervision of a physician, not for use\nwhen drug is self-administered) *\n“J0775” Injection, collagenase, clostridium histolyticum, 0.01 mg *\n“J2440” Injection, papaverine hydrochloride injection (HCI), up to 60 mg *\n“J2760” Injection, phentolamine mesylate, up to 5 mg *\n“L7900” Male vacuum erection system\n“L7902” Tension ring, for vacuum erection device, any type, replacement only,\neach\n*Please note: In the inpatient setting, alprostadil and papaverine may be covered for the treatment of a condition other than sexual\nor erectile dysfunction for which the drugs have been approved by the Food and Drug Administration (FDA). Additionally, physician-\nadministered collagenase, clostridium histolyticum and phentolamine mesylate may be covered for the treatment of a condition, other\nthan sexual or erectile dysfunction, for which the drug has been approved by the ", "chunk_type": "text"}
{"doc_id": "mu_no11_sep21_pr.pdf", "chunk_id": "mu_no11_sep21_pr.pdf::0006", "char_start": 10500, "char_end": 12500, "pages": [4, 5], "text": "tion (FDA). Additionally, physician-\nadministered collagenase, clostridium histolyticum and phentolamine mesylate may be covered for the treatment of a condition, other\nthan sexual or erectile dysfunction, for which the drug has been approved by the FDA and prior approval has been received.\nSeptember 2021 New York State Medicaid Update pg. 4\n\nInternational\nClassification of\nDiseases, Tenth Revision Descriptions\n(ICD-10) Inpatient\nProcedures\n“0VHS03Z” Insertion of Infusion Device into Penis, Open Approach\n“0VHS0YZ” Insertion of Other Device into Penis, Open Approach\n“0VHS33Z” Insertion of Infusion Device into Penis, Percutaneous Approach\n“0VHS3YZ” Insertion of Other Device into Penis, Percutaneous Approach\n“0VHS4YZ” Insertion of Other Device into Penis, Percutaneous Endoscopic Approach\n“0VHS7YZ” Insertion of Other Device into Penis, Via Natural or Artificial Opening\n“0VHS8YZ” Insertion of Other Device into Penis, Via Natural or Artificial Opening\nEndoscopic\n“0VHSX3Z” Insertion of Infusion Device into Penis, External Approach\n“0VUS07Z” Supplement Penis with Autologous Tissue Substitute, Open Approach\n“0VUS0JZ” Supplement Penis with Synthetic Substitute, Open Approach\n“0VUS0KZ” Supplement Penis with Nonautologous Tissue Substitute, Open Approach\n“0VUS47Z” Supplement Penis with Autologous Tissue Substitute, Percutaneous\nEndoscopic Approach\n“0VUS4JZ” Supplement Penis with Synthetic Substitute, Percutaneous Endoscopic\nApproach\n“0VUS4KZ” Supplement Penis with Nonautologous Tissue Substitute, Percutaneous\nEndoscopic Approach\n“0VUSX7Z” Supplement Penis with Autologous Tissue Substitute, External Approach\n“0VUSXJZ” Supplement Penis with Synthetic Substitute, External Approach\n“0VUSXKZ” Supplement Penis with Nonautologous Tissue Substitute, External Approach\n“0VWS07Z” Revision of Autologous Tissue Substitute in Penis, Open Approach\n“0VWS0JZ” Revision of Synthetic Substitute in Penis, Open Approach\n“0VWS0KZ” Revision of Nonautologous Tissue Substitute in Penis, Open Approach\n“0", "chunk_type": "text"}
{"doc_id": "mu_no11_sep21_pr.pdf", "chunk_id": "mu_no11_sep21_pr.pdf::0007", "char_start": 12250, "char_end": 14250, "pages": [5, 6], "text": "bstitute, External Approach\n“0VWS07Z” Revision of Autologous Tissue Substitute in Penis, Open Approach\n“0VWS0JZ” Revision of Synthetic Substitute in Penis, Open Approach\n“0VWS0KZ” Revision of Nonautologous Tissue Substitute in Penis, Open Approach\n“0VWS47Z” Revision of Autologous Tissue Substitute in Penis, Percutaneous Endoscopic\nApproach\n“0VWS4JZ Revision of Synthetic Substitute in Penis, Percutaneous Endoscopic\nApproach\n“0VWS4KZ” Revision of Nonautologous Tissue Substitute in Penis, Percutaneous\nEndoscopic Approach\n“0VWSX7Z” Revision of Autologous Tissue Substitute in Penis, External Approach\n“0VWSXJZ” Revision of Synthetic Substitute in Penis, External Approach\n“0VWSXKZ” Revision of Nonautologous Tissue Substitute in Penis, External Approach\n“0VY50Z0” Transplantation of Scrotum, Allogeneic, Open Approach\n“0VY50Z1” Transplantation of Scrotum, Syngeneic, Open Approach\n“0VY50Z2” Transplantation of Scrotum, Zooplastic, Open Approach\n“0VYS0Z0” Transplantation of Penis, Allogeneic, Open Approach\n“0VYS0Z1” Transplantation of Penis, Syngeneic, Open Approach\n“0VYS0Z2” Transplantation of Penis, Zooplastic, Open Approach\nPlease note: This list provides all known procedures at the time of publication but may not be all-inclusive. Providers are encouraged\nto use their clinical knowledge to apply this policy to similar drugs, procedures, and supplies. For specific questions, providers should\ncontact the respective agency below. Managed Care providers should also contact their contracted MMC Plans for a comprehensive\nlist of codes that may be excluded.\nSeptember 2021 New York State Medicaid Update pg. 5\n\nQuestions and Additional Information:\n• Medicaid FFS coverage and policy questions should be directed to the Office of Health Insurance\nPrograms (OHIP) Division of Program Development and Management (DPDM) by phone at (518) 473-\n2160 or by email at FFSMedicaidPolicy@health.ny.gov.\n• Medicaid FFS claim questions should be directed to the eMedNY Call Center at (800) 343-9000.\n• ", "chunk_type": "text"}
{"doc_id": "mu_no11_sep21_pr.pdf", "chunk_id": "mu_no11_sep21_pr.pdf::0008", "char_start": 14000, "char_end": 16000, "pages": [6, 7], "text": "urance\nPrograms (OHIP) Division of Program Development and Management (DPDM) by phone at (518) 473-\n2160 or by email at FFSMedicaidPolicy@health.ny.gov.\n• Medicaid FFS claim questions should be directed to the eMedNY Call Center at (800) 343-9000.\n• MMC general coverage questions should be directed to OHIP Division of Health Plan Contracting and\nOversight (DHPCO) by email at covques@health.ny.gov or by phone at (518) 473-1134.\n• MMC reimbursement and/or billing requirements questions should be directed to the enrollee’s MMC\nPlan. Providers can refer to the NYS Medicaid Program Information for All Providers: Managed Care\nInformation document at: https://www.emedny.org/ProviderManuals/iAllProviders/PDFS/Information_\nfor_All_Providers_Managed_Care_Information.pdf.\n• PA questions should be directed to the OHIP Division of Operations and Systems (DOS) at (800) 342-\n3005.\n***************************************************************************************************************\nSeptember 2021 New York State Medicaid Update pg. 6\n\nAll Providers\nMedicaid Consumer Fact Sheets Now Available\nFollowing a recommendation from the Medicaid Redesign Team (MRT) II, the New York State (NYS)\nDepartment of Health (DOH) Office of Health Insurance Programs (OHIP) created Medicaid consumer fact\nsheets focused on chronic health conditions. Each fact sheet provides information regarding how a condition\ncan be prevented or managed, as well as relevant Medicaid benefits that can be used to help members stay\nhealthy. Topics include sickle cell disease, diabetes, high blood pressure, asthma control, HIV-PrEP (Human\nImmunodeficiency Virus - Pre-Exposure Prophylaxis), and smoking cessation. Fact sheets can be found on\nthe NYS DOH “MRT II Policies and Guidance” web page, at: https://health.ny.gov/health_care/medicaid/\nredesign/mrt2/policy/index.htm, and are available in English, Spanish, Traditional Chinese, Russian, Haitian\nCreole, Bengali, and Korean. The most recently added Sickle Cell Dise", "chunk_type": "text"}
{"doc_id": "mu_no11_sep21_pr.pdf", "chunk_id": "mu_no11_sep21_pr.pdf::0009", "char_start": 15750, "char_end": 17750, "pages": [7], "text": "and Guidance” web page, at: https://health.ny.gov/health_care/medicaid/\nredesign/mrt2/policy/index.htm, and are available in English, Spanish, Traditional Chinese, Russian, Haitian\nCreole, Bengali, and Korean. The most recently added Sickle Cell Disease fact sheet is also available in\nSimplified Chinese, Polish, Yiddish, Arabic, and Italian.\n***************************************************************************************************************\nNY State of Health: Higher Income New Yorkers May Now Qualify\nfor Financial Assistance to Lower the Cost of Health Coverage\nNew federal financial assistance is now available through NY State of Health to qualifying, higher-income\nindividuals. This financial assistance is being implemented as part of the American Rescue Plan Act (ARPA)\nsigned into law on March 11, 2021, which can be found at: https://www.congress.gov/bill/117th-\ncongress/house-bill/1319/text.\nNearly 120,000 enrollees with income below 400 percent federal poverty level (FPL) are already receiving\nenhanced tax credits and nearly 18,000 higher-income enrollees are eligible for these federal tax credits for\nthe first time. Higher-income individuals enrolled outside of NY State of Health and uninsured individuals may\nalso be eligible for enhanced tax credits available through NY State of Health. Before the ARPA, tax credits\nwere not available to higher-income individuals and their families (i.e., those earning more than $51,040 and\nfamilies of four earning more than $104,800). Through the ARPA, these federal tax credits are available to\nthese individuals and their families when enrolling in a health plan through NY State of Health.\nIndividuals with low and moderate incomes (i.e., those earning up to $51,040 and families of four earning up\nto $104,800) who were previously eligible for tax credits are now eligible for higher tax credits. NY State of\nHealth automatically applied higher tax credits without enrollees needing to take any action. Enrollees can\nmake", "chunk_type": "text"}
{"doc_id": "mu_no11_sep21_pr.pdf", "chunk_id": "mu_no11_sep21_pr.pdf::0010", "char_start": 17500, "char_end": 19500, "pages": [7, 8], "text": "amilies of four earning up\nto $104,800) who were previously eligible for tax credits are now eligible for higher tax credits. NY State of\nHealth automatically applied higher tax credits without enrollees needing to take any action. Enrollees can\nmake changes to their account by logging into their NY State of Health account, contacting an Enrollment\nAssistor, and/or calling NY State of Health at (855) 355-5777.\nTo allow as many individuals as possible to access these enhanced tax credits, the 2021 Open Enrollment\nPeriod has been extended through December 31, 2021. Individuals and families can apply for coverage\nthrough the NY State of Health website at: http://www.nystateofhealth.ny.gov, by phone at (855) 355-5777,\nor by connecting with a free enrollment assistor via the NY State of Health “Find a Broker/Navigator” search\ntool at: https://nystateofhealth.ny.gov/agent/hx_brokerSearch?fromPage=INDIVIDUAL&lang=en.\nAdditional Information\nTo read more about how NY State of Health enrollees benefit from the ARPA, providers can visit the How NY\nState of Health Enrollees Benefit from the American Rescue Plan web page, found at:\nhttps://info.nystateofhealth.ny.gov/americanrescueplan.\n***************************************************************************************************************\nSeptember 2021 New York State Medicaid Update pg. 7\n\nClozapine Risk Evaluation and Mitigation Strategy Deadline\nEffective immediately, all providers and pharmacies that prescribe or dispense clozapine must re-\ncertify in the Clozapine Risk Evaluation and Mitigation Strategy (REMS) by November 15, 2021.\nClozapine is Food and Drug Administration (FDA)-approved for treatment-resistant Schizophrenia and to\nreduce the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder.\nClozapine is associated with severe neutropenia [absolute neutrophil count (ANC) less than 500/μL], and as\npart of the REMS, patient ANCs must be submitted monthly via Patient Status", "chunk_type": "text"}
{"doc_id": "mu_no11_sep21_pr.pdf", "chunk_id": "mu_no11_sep21_pr.pdf::0011", "char_start": 19250, "char_end": 21250, "pages": [8, 9], "text": "ehavior in patients with schizophrenia or schizoaffective disorder.\nClozapine is associated with severe neutropenia [absolute neutrophil count (ANC) less than 500/μL], and as\npart of the REMS, patient ANCs must be submitted monthly via Patient Status forms.\nFor prescribers, re-certification is required regardless of outpatient or inpatient setting. Providers and\npharmacies that fail to re-certify cannot prescribe or dispense clozapine. Providers/pharmacies must also re-\nenroll their patients in Clozapine REMS by November 15, 2021. Patients who are not re-enrolled by their\nproviders into Clozapine REMS cannot receive clozapine.\nThe modifications to the Clozapine REMS, which include the prescribing, dispensing, and receiving of\nclozapine into a single-shared program, were approved on July 29, 2021 by the FDA and can be found on\nthe FDA “Clozapine Risk Evaluation and Mitigation Strategy (REMS) requirements will change on November\n15, 2021” web page at: https://www.fda.gov/drugs/drug-safety-and-availability/clozapine-risk-evaluation-and-\nmitigation-strategy-rems-requirements-will-change-november-15-2021. Providers and pharmacies can re-\ncertify or re-enroll their patients into the program by visiting the “Clozapine REMS” home page\nat https://www.newclozapinerems.com/home.\n***************************************************************************************************************\nSeptember 2021 New York State Medicaid Update pg. 8\n\nProvider Directory\nOffice of the Medicaid Inspector General:\nFor suspected fraud, waste or abuse complaints/allegations, call 1-877-87FRAUD, (877) 873-7283, or visit\nOffice of Medicaid Inspector General (OMIG) web site at: www.omig.ny.gov.\nProvider Manuals/Companion Guides, Enrollment Information/Forms/Training Schedules:\nPlease visit the eMedNY website at: www.emedny.org.\nProviders wishing to listen to the current week’s check/EFT amounts:\nPlease call (866) 307-5549 (available Thursday PM for one week for the current week's amount).\nFor qu", "chunk_type": "text"}
{"doc_id": "mu_no11_sep21_pr.pdf", "chunk_id": "mu_no11_sep21_pr.pdf::0012", "char_start": 21000, "char_end": 22653, "pages": [9], "text": "n/Forms/Training Schedules:\nPlease visit the eMedNY website at: www.emedny.org.\nProviders wishing to listen to the current week’s check/EFT amounts:\nPlease call (866) 307-5549 (available Thursday PM for one week for the current week's amount).\nFor questions about billing and performing MEVS transactions:\nPlease call the eMedNY Call Center at (800) 343-9000.\nProvider Training:\nPlease enroll online for a provider seminar at: https://www.emedny.org/training/index.aspx. For\nindividual training requests, call (800) 343-9000.\nBeneficiary Eligibility:\nCall the Touchtone Telephone Verification System at (800) 997-1111.\nMedicaid Prescriber Education Program:\nFor current information on best practices in pharmacotherapy, please visit the following web sites:\n• DOH Prescriber Education Program page:\nhttps://www.health.ny.gov/health_care/medicaid/program/prescriber_education/presc-\neducationprog.\n• Prescriber Education Program in partnership with SUNY: http://nypep.nysdoh.suny.edu/.\neMedNY\nFor a number of services, including: change of address, updating an enrollment file due to an\nownership change, enrolling another NPI, or revalidating an existing enrollment, please visit the\neMedNY Provider Enrollment page at: https://www.emedny.org/info/ProviderEnrollment/index.aspx,\nand choose the appropriate link based on provider type.\nNY Medicaid Electronic Health Record (EHR) Incentive Program\nContact the New York Medicaid EHR Call Center at (877) 646-5410 for assistance.\nComments and Suggestions Regarding This Publication\nPlease contact the editor, Angela Lince, at medicaidupdate@health.ny.gov.\nSeptember 2021 New York State Medicaid Update pg. 9", "chunk_type": "text"}
{"doc_id": "mu_no11_sep21_pr.pdf", "chunk_id": "mu_no11_sep21_pr.pdf::0013", "char_start": 22403, "char_end": 22653, "pages": [9], "text": " the New York Medicaid EHR Call Center at (877) 646-5410 for assistance.\nComments and Suggestions Regarding This Publication\nPlease contact the editor, Angela Lince, at medicaidupdate@health.ny.gov.\nSeptember 2021 New York State Medicaid Update pg. 9", "chunk_type": "text"}
{"doc_id": "mu_no11_sep21_pr.pdf", "chunk_id": "mu_no11_sep21_pr.pdf::0014::table", "char_start": null, "char_end": null, "pages": [4], "text": ",Current Procedural,,Descriptions\r\n,Terminology (CPT) Codes,,\r\n,and Physician administered,,\r\n,(J-Code Drugs),,\r\n“37788”,,,\"Penile revascularization, artery, with or without vein graft\"\r\n“37790”,,,Penile venous occlusive procedure\r\n“54400”,,,Insertion of penile prosthesis; non-inflatable (semi-rigid)\r\n“54401”,,,Insertion of penile prosthesis; inflatable (self-contained)\r\n“54405”,,,\"Insertion of multi-component, inflatable penile prosthesis, including\nplacement of pump, cylinders, and reservoir\"\r\n“54408”,,,\"Repair of component(s) of a multi-component, inflatable penile prosthesis\"\r\n“54410”,,,\"Removal and replacement of all component(s) of a multi-component,\ninflatable penile prosthesis at the same operative session\"\r\n“54411”,,,\"Removal and replacement of all components of a multi-component\ninflatable penile prosthesis through an infected field at the same operative\nsession, including irrigation and debridement of infected tissue\"\r\n“54416”,,,\"Removal and replacement of non-inflatable (semi-rigid) or inflatable (self-\ncontained) penile prosthesis at the same operative session\"\r\n“54417”,,,\"Removal and replacement of non-inflatable (semi-rigid) or inflatable (self-\ncontained) penile prosthesis through an infected field at the same\noperative session, including irrigation and debridement of infected tissue\"\r\n“55870”,,,Electroejaculation\r\n“J0270”,,,\"Injection, alprostadil, 1.25 mcg (code may be used for Medicare when\ndrug administered under the direct supervision of a physician, not for use\nwhen drug is self-administered) *\"\r\n“J0275”,,,\"Alprostadil urethral suppository (code may be used for Medicare when\ndrug administered under the direct supervision of a physician, not for use\nwhen drug is self-administered) *\"\r\n“J0775”,,,\"Injection, collagenase, clostridium histolyticum, 0.01 mg *\"\r\n“J2440”,,,\"Injection, papaverine hydrochloride injection (HCI), up to 60 mg *\"\r\n“J2760”,,,\"Injection, phentolamine mesylate, up to 5 mg *\"\r\n“L7900”,,,Male vacuum erection system\r\n“L7902”,,,\"Tension ring, for vacuum erection device, any type, replacement only,\neach\"\r\n", "chunk_type": "table"}
{"doc_id": "mu_no11_sep21_pr.pdf", "chunk_id": "mu_no11_sep21_pr.pdf::0015::table", "char_start": null, "char_end": null, "pages": [4], "text": "\"\"\r\nDescriptions\r\n", "chunk_type": "table"}
{"doc_id": "mu_no11_sep21_pr.pdf", "chunk_id": "mu_no11_sep21_pr.pdf::0016::table", "char_start": null, "char_end": null, "pages": [5], "text": ",International,,Descriptions\r\n,Classification of,,\r\n,\"Diseases, Tenth Revision\",,\r\n,(ICD-10) Inpatient,,\r\n,Procedures,,\r\n“0VHS03Z”,,,\"Insertion of Infusion Device into Penis, Open Approach\"\r\n“0VHS0YZ”,,,\"Insertion of Other Device into Penis, Open Approach\"\r\n“0VHS33Z”,,,\"Insertion of Infusion Device into Penis, Percutaneous Approach\"\r\n“0VHS3YZ”,,,\"Insertion of Other Device into Penis, Percutaneous Approach\"\r\n“0VHS4YZ”,,,\"Insertion of Other Device into Penis, Percutaneous Endoscopic Approach\"\r\n“0VHS7YZ”,,,\"Insertion of Other Device into Penis, Via Natural or Artificial Opening\"\r\n“0VHS8YZ”,,,\"Insertion of Other Device into Penis, Via Natural or Artificial Opening\nEndoscopic\"\r\n“0VHSX3Z”,,,\"Insertion of Infusion Device into Penis, External Approach\"\r\n“0VUS07Z”,,,\"Supplement Penis with Autologous Tissue Substitute, Open Approach\"\r\n“0VUS0JZ”,,,\"Supplement Penis with Synthetic Substitute, Open Approach\"\r\n“0VUS0KZ”,,,\"Supplement Penis with Nonautologous Tissue Substitute, Open Approach\"\r\n“0VUS47Z”,,,\"Supplement Penis with Autologous Tissue Substitute, Percutaneous\nEndoscopic Approach\"\r\n“0VUS4JZ”,,,\"Supplement Penis with Synthetic Substitute, Percutaneous Endoscopic\nApproach\"\r\n“0VUS4KZ”,,,\"Supplement Penis with Nonautologous Tissue Substitute, Percutaneous\nEndoscopic Approach\"\r\n“0VUSX7Z”,,,\"Supplement Penis with Autologous Tissue Substitute, External Approach\"\r\n“0VUSXJZ”,,,\"Supplement Penis with Synthetic Substitute, External Approach\"\r\n“0VUSXKZ”,,,\"Supplement Penis with Nonautologous Tissue Substitute, External Approach\"\r\n“0VWS07Z”,,,\"Revision of Autologous Tissue Substitute in Penis, Open Approach\"\r\n“0VWS0JZ”,,,\"Revision of Synthetic Substitute in Penis, Open Approach\"\r\n“0VWS0KZ”,,,\"Revision of Nonautologous Tissue Substitute in Penis, Open Approach\"\r\n“0VWS47Z”,,,\"Revision of Autologous Tissue Substitute in Penis, Percutaneous Endoscopic\nApproach\"\r\n“0VWS4JZ,,,\"Revision of Synthetic Substitute in Penis, Percutaneous Endoscopic\nApproach\"\r\n“0VWS4KZ”,,,\"Revision of Nonautologous Tissue Substitute in Penis, Percutaneous\nEndoscopic Approach\"\r\n“0VWSX7Z”,,,\"Revision of Autologous Tissue Substitute in Penis, External Approach\"\r\n“0VWSXJZ”,,,\"Revision of Synthetic Substitute in Penis, External Approach\"\r\n“0VWSXKZ”,,,\"Revision of Nonautologous Tissue Substitute in Penis, External Approach\"\r\n“0VY50Z0”,,,\"Transplantation of Scrotum, Allogeneic, Open Approach\"\r\n“0VY50Z1”,,,\"Transplantation of Scrotum, Syngeneic, Open Approach\"\r\n“0VY50Z2”,,,\"Transplantation of Scrotum, Zooplastic, Open Approach\"\r\n“0VYS0Z0”,,,\"Transplantation of Penis, Allogeneic, Open Approach\"\r\n“0VYS0Z1”,,,\"Transplantation of Penis, Syngeneic, Open Approach\"\r\n“0VYS0Z2”,,,\"Transplantation of Penis, Zooplastic, Open Approach\"\r\n", "chunk_type": "table"}
{"doc_id": "mu_no11_sep21_pr.pdf", "chunk_id": "mu_no11_sep21_pr.pdf::0017::table", "char_start": null, "char_end": null, "pages": [5], "text": "\"\"\r\n\"\"\r\nDescriptions\r\n", "chunk_type": "table"}
